Drug Addiction Clinical Trial
Official title:
Early Warning Model Construction on Cognition, Resistance and Using Risk of the New Psychoactive Substances in Adolescents Based on Behavioral Expression of Addiction Susceptibility Genes and Adverse Childhood Experience
Based on the biological-psychology-sociological medicine pattern, this study aims to construction an early warning model of the New Psychoactive Substances (NPS) using for adolescents aged 14-35 years old. This study intends to obtain the data related to the behavioral expression of addiction susceptibility genes, adverse childhood experience, cognition, resistance and the use of NPS in adolescents by questionnaire survey (sample size: 200), and then use logistic regression and machine learning to construct an early warning model.
Status | Not yet recruiting |
Enrollment | 200 |
Est. completion date | November 30, 2023 |
Est. primary completion date | October 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 14 Years to 35 Years |
Eligibility | Inclusion Criteria: - Adolescents aged 14-35 (including 14,35 years old) - Agree to participate in the studies Exclusion Criteria: - Be diagnosed with psychological or mental illness - People that are unconscious, emotionally unstable, or unable to communicate normally - Patients with severe diseases |
Country | Name | City | State |
---|---|---|---|
China | Sun Yat-sen University | Guangzhou | Guangdong |
Lead Sponsor | Collaborator |
---|---|
Wei XIA, PhD |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the cognition of NPS | knowledge questionnaire of drug types and risk awareness of drug use will be investigated to know the degree of cognition to NPS | Baseline | |
Primary | the resistance of NPS | the drug refusal self-efficacy scale and the drug use permissive attitude will be used to measure the the resistance of NPS | Baseline | |
Primary | the use of NPS | there will be some questions to investigate the drug use conditions | Baseline | |
Primary | Adverse Childhood Experience | the Chinese version of Adverse Childhood Experience Scale with 10 items will be used to measure the adverse childhood experience | Baseline | |
Primary | hedonic hunger | the Power of Food Scale with 15 items will be used to measure hedonic hunger | Baseline | |
Primary | sensation seeking personality | the Brief Sensation Seeking Scale for Chinese with 8 items will be used to measure sensation seeking personality | Baseline | |
Primary | prosocial behavior | the Prosocial Tendencies Measure with 26 items will be used to measure prosocial behavior | Baseline | |
Primary | externalizing behavior | 17 items of aggressive behavior and 15 items of rule-breaking behavior from the Chinese Version of Achenbach Youth Self-Report-2001 Version will be used to measure adolescents' degree of externalizing behavior | Baseline | |
Primary | sleep quality | the Pittsburgh Sleep Quality Index with 9 items will be used to measure adolescents' sleep quality | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02192931 -
A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users
|
Phase 4 | |
Completed |
NCT02282306 -
Phone Interview to Prevent Recurring Opioid Overdoses
|
N/A | |
Completed |
NCT02939352 -
The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues
|
Early Phase 1 | |
Completed |
NCT02437123 -
The Cedar Project: Impact of mHealth for HIV Prevention Among Young Indigenous People Who Use Illicit Drugs
|
N/A | |
Completed |
NCT02224508 -
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
|
N/A | |
Completed |
NCT01685073 -
The Role of Sleep in the Treatment of Cannabis Use Disorders
|
Phase 2/Phase 3 | |
Completed |
NCT01591239 -
Home-Based Program to Help Parents of Drug Abusing Adolescents
|
N/A | |
Completed |
NCT00317460 -
Buprenorphine and Integrated HIV Care
|
Phase 4 | |
Completed |
NCT03678051 -
CBT4CBT for Women in Residential Treatment for Substance Use Disorders
|
N/A | |
Completed |
NCT04105621 -
Westlake Personalized Nutrition and Health Cohort for Drug Addicts
|
||
Withdrawn |
NCT05440721 -
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
|
N/A | |
Completed |
NCT03694327 -
Innovative Digital Therapeutic for Smoking Cessation
|
N/A | |
Completed |
NCT00244699 -
Integrating Mindfulness-Based Skills Training Into Brief Outpatient Treatment for Substance Abusing Youth
|
N/A | |
Completed |
NCT00496990 -
Treating the Partners of Drug Using Pregnant Women: Stage II
|
Phase 2/Phase 3 | |
Completed |
NCT00390559 -
Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3
|
N/A | |
Completed |
NCT03411265 -
RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing
|
N/A | |
Completed |
NCT03402672 -
AWAITS: A Web-based E-health Application for Active Illicit Opioid Users
|
N/A | |
Completed |
NCT01003496 -
Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial
|
Phase 3 | |
Completed |
NCT02091284 -
Bilateral Prefrontal Modulation in Alcoholism
|
N/A | |
Completed |
NCT02091167 -
Bilateral Prefrontal Modulation in Crack-cocaine Addiction
|
Phase 2 |